How do analysts rate AbbVie (abbv) stock?

Within the last quarter, AbbVie (NYSE: ABBV) has observed the following analyst ratings: According to 8 analyst offering 12-month price targets in the last 3 months, AbbVie has an average price target of $169.38 with a high of $200.00 and a low of $140.00. Below is a summary of how these 8 analysts rated AbbVie over the past 3 months.

Is AbbVie’s stock still a buy at $121?

The stock price of AbbVie (NYSE: ABBV) reached its 52-week high of around $121 just last week before a recent sell-off in ABBV stock, especially after the U.S. FDA stated that all janus kinase inhibitors approved for arthritis treatment should carry a heart-risk warning on the label – sending the stock to lower levels of $112 currently.

What is the average return for AbbVie stock?

IF ABBV stock moved by -5% over five trading days, THEN over the next twenty-one trading days ABBV stock moves an average of 3%, with a good 66% probability of a positive return over this period. Question 1: Is the average return for AbbVie stock higher after a drop?